Mesalamine
Mesalamine is an active ingredient in 63 FDA-listed drug products sold under 7 names.
Drugs containing Mesalamine
- Mesalamine 56
- Pentasa 2
- Apriso 1
- Rowasa 1
- Mesalamine Rectal 1
- Lialda 1
- Canasa 1
Products and strengths
| NDC | Product | Strength | Labeler |
|---|---|---|---|
| 65649-103 | Apriso Capsule, Extended Release | 375 mg/1 | Salix Pharmaceuticals, Inc. |
| 58914-501 | Canasa Suppository | 1000 mg/1 | Allergan, Inc. |
| 54092-476 | Lialda Tablet, Delayed Release | 1.2 g/1 | Takeda Pharmaceuticals America, Inc. |
| 0472-1915 | Mesalamine Suppository | 1000 mg/1 | Actavis Pharma, Inc. |
| 0591-2245 | Mesalamine Tablet, Delayed Release | 1.2 g/1 | Actavis Pharma, Inc. |
| 62332-724 | Mesalamine Capsule, Extended Release | .375 g/1 | Alembic Pharmaceuticals Inc. |
| 46708-724 | Mesalamine Capsule, Extended Release | .375 g/1 | Alembic Pharmaceuticals Limited |
| 60687-556 | Mesalamine Capsule, Delayed Release | 400 mg/1 | American Health Packaging |
| 60687-397 | Mesalamine Tablet, Delayed Release | 1.2 g/1 | American Health Packaging |
| 60687-408 | Mesalamine Tablet, Delayed Release | 800 mg/1 | American Health Packaging |
| 60687-650 | Mesalamine Capsule, Extended Release | .375 g/1 | American Health Packaging |
| 65162-360 | Mesalamine Tablet, Delayed Release | 800 mg/1 | Amneal Pharmaceuticals LLC |
| 62559-420 | Mesalamine Enema | 4 g/60mL | ANI Pharmaceuticals, Inc. |
| 70954-301 | Mesalamine Suspension | 4 g/60mL | ANI Pharmaceuticals, Inc. |
| 67877-717 | Mesalamine Capsule, Extended Release | .375 g/1 | Ascend Laboratories, LLC |
| 59651-397 | Mesalamine Capsule, Extended Release | .375 g/1 | Aurobindo Pharma Limited |
| 42291-489 | Mesalamine Tablet, Delayed Release | 800 mg/1 | AvKARE |
| 50268-577 | Mesalamine Capsule, Extended Release | .375 g/1 | AvPAK |
| 63629-2397 | Mesalamine Suppository | 1000 mg/1 | Bryant Ranch Prepack |
| 72162-1804 | Mesalamine Suppository | 1000 mg/1 | Bryant Ranch Prepack |
| 72162-2231 | Mesalamine Tablet, Delayed Release | 1.2 g/1 | Bryant Ranch Prepack |
| 72162-2213 | Mesalamine Tablet, Delayed Release | 1.2 g/1 | Bryant Ranch Prepack |
| 72162-2302 | Mesalamine Suspension | 4 g/60mL | Bryant Ranch Prepack |
| 31722-043 | Mesalamine Tablet, Delayed Release | 1.2 g/1 | Camber Pharmaceuticals, Inc. |
| 31722-005 | Mesalamine Suppository | 1000 mg/1 | Camber Pharmaceuticals, Inc. |
| 31722-489 | Mesalamine Capsule, Extended Release | 375 mg/1 | Camber Pharmaceuticals, Inc. |
| 62135-714 | Mesalamine Tablet, Delayed Release | 1.2 g/1 | Chartwell RX, LLC |
| 21922-045 | Mesalamine Suspension | 4 g/60mL | Encube Ethicals, Inc. |
| 51407-976 | Mesalamine Capsule, Extended Release | .375 g/1 | Golden State Medical Supply, Inc. |
| 51407-900 | Mesalamine Tablet, Delayed Release | 1.2 g/1 | Golden State Medical Supply, Inc. |
| 50742-371 | Mesalamine Capsule, Extended Release | .375 g/1 | Ingenus Pharmaceuticals, LLC |
| 84725-002 | Mesalamine Suspension | 4 g/60mL | KLM Laboratories Private Limited |
| 0527-3012 | Mesalamine Tablet, Delayed Release | 1.2 g/1 | Lannett Company Inc. |
| 0904-6832 | Mesalamine Tablet, Delayed Release | 1.2 g/1 | Major Pharmaceuticals |
| 0378-1375 | Mesalamine Capsule, Extended Release | .375 g/1 | Mylan Pharmaceuticals Inc. |
| 16714-245 | Mesalamine Suppository | 1000 mg/1 | Northstar Rx LLC. |
| 72603-304 | Mesalamine Tablet, Delayed Release | 1.2 g/1 | NorthStar RxLLC |
| 84612-175 | Mesalamine Tablet, Delayed Release | 1.2 g/1 | Nuvaila Limited |
| 68682-113 | Mesalamine Capsule, Extended Release | 375 mg/1 | Oceanside Pharmaceuticals |
| 45802-098 | Mesalamine Enema | 4 g/60mL | Padagis Israel Pharmaceuticals Ltd |
| 16571-246 | Mesalamine Suppository | 1000 mg/1 | Rising Pharma Holdings, Inc. |
| 64980-282 | Mesalamine Suppository | 1000 mg/1 | Rising Pharma Holdings, Inc. |
| 0781-2793 | Mesalamine Capsule, Extended Release | 500 mg/1 | Sandoz Inc |
| 0781-2791 | Mesalamine Capsule, Extended Release | 250 mg/1 | Sandoz Inc |
| 63304-089 | Mesalamine Capsule, Extended Release | 500 mg/1 | Sun Pharmaceutical Industries Inc. |
| 63304-175 | Mesalamine Tablet, Delayed Release | 1.2 g/1 | Sun Pharmaceutical Industries, Inc. |
| 54092-100 | Mesalamine Tablet, Delayed Release | 1.2 g/1 | Takeda Pharmaceuticals America, Inc. |
| 0093-9224 | Mesalamine Capsule, Extended Release | 375 mg/1 | Teva Pharmaceuticals USA, Inc. |
| 0093-5907 | Mesalamine Capsule, Delayed Release | 400 mg/1 | Teva Pharmaceuticals USA, Inc. |
| 0480-7750 | Mesalamine Tablet, Delayed Release | 800 mg/1 | Teva Pharmaceuticals, Inc. |
| 0832-6056 | Mesalamine Capsule, Extended Release | .375 g/1 | Upsher-Smith Laboratories, LLC |
| 70771-1110 | Mesalamine Tablet, Delayed Release | 800 mg/1 | Zydus Lifesciences Limited |
| 70771-1625 | Mesalamine Capsule, Extended Release | .375 g/1 | Zydus Lifesciences Limited |
| 70771-1071 | Mesalamine Tablet, Delayed Release | 1.2 g/1 | Zydus Lifesciences Limited |
| 70771-1513 | Mesalamine Suppository | 1000 mg/1 | Zydus Lifesciences Limited |
| 68382-452 | Mesalamine Capsule, Extended Release | .375 g/1 | Zydus Pharmaceuticals USA Inc. |
| 68382-435 | Mesalamine Tablet, Delayed Release | 800 mg/1 | Zydus Pharmaceuticals USA Inc. |
| 68382-711 | Mesalamine Tablet, Delayed Release | 1.2 g/1 | Zydus Pharmaceuticals USA Inc. |
| 70710-1302 | Mesalamine Suppository | 1000 mg/1 | Zydus Pharmaceuticals USA Inc. |
| 69918-560 | Mesalamine Rectal Suppository | 1000 mg/1 | Amring Pharmaceuticals Inc. |
| 54092-191 | Pentasa Capsule | 500 mg/1 | Takeda Pharmaceuticals America, Inc. |
| 54092-189 | Pentasa Capsule | 250 mg/1 | Takeda Pharmaceuticals America, Inc. |
| 0037-0066 | Rowasa Suspension | 4 g/60mL | Viatris Specialty LLC |